Down-regulation of Mu-opioid Receptor by Full but Not Partial Agonists is Independent of G Protein Coupling
Overview
Pharmacology
Authors
Affiliations
In C6 glial cells stably expressing rat mu-opioid receptor, opioid agonist activation is negatively coupled to adenylyl cyclase through pertussis toxin-sensitive G proteins. In membranes, [D-Ala2, N-MePhe4,Gly-ol5]enkephalin (DAMGO) increases guanosine-5'-O-(3-[35S]thio)triphosphate (GTP[gamma-35S]) binding by 367% with an EC50 value of 28 nM. Prolonged exposure to agonists induced desensitization of the receptor as estimated by a reduction in the maximal stimulation of GTP[gamma-35S] binding by DAMGO and rightward shifts in the dose-response curves. In cells treated with 10 microM concentrations of etorphine, DAMGO, beta-endorphin, morphine, and butorphanol, DAMGO-stimulated GTP[gamma-35S] binding was 58%, 149%, 205%, 286%, and 325%, respectively. Guanine nucleotide regulation of agonist binding was correspondingly lower in membranes from tolerant cells. Furthermore, chronic opioid treatment increased forskolin-stimulated adenylyl cyclase activity, and potency of DAMGO to inhibit cAMP accumulation was lower in morphine- and DAMGO-tolerant cells (EC50 = 55 and 170 nM versus 18 nM for control). Chronic treatment with agonists reduced [3H]DAMGO binding in membranes with the rank order of etorphine > DAMGO = beta-endorphin > morphine > butorphanol, and the affinity of DAMGO in alkaloid- but not peptide-treated membranes was significantly lower in comparison with control. Pertussis toxin treatment of the cells before agonist treatment did not prevent the down-regulation by full agonists; DAMGO and etorphine exhibited approximately 80% internalization, whereas the ability of partial agonists was greatly impaired. In addition to establishing this cell line as a good model for further studies on the mechanisms of opioid tolerance, these results indicate important differences in the inactivation pathways of receptor triggered by full and partial agonists.
Sex-dependent impact of microbiota status on cerebral μ-opioid receptor density in fischer rats.
Effah F, de Gusmao Taveiros Silva N, Vijayanathan K, Camarini R, Joly F, Taiwo B Eur J Neurosci. 2022; 55(8):1917-1933.
PMID: 35393704 PMC: 9324823. DOI: 10.1111/ejn.15666.
Activation of nucleus accumbens μ-opioid receptors enhances the response to a glycaemic challenge.
Koekkoek L, Kool T, Eggels L, van der Gun L, Lamuadni K, Slomp M J Neuroendocrinol. 2021; 33(10):e13036.
PMID: 34528311 PMC: 9286654. DOI: 10.1111/jne.13036.
Chen W, Ennes H, McRoberts J, Marvizon J Neuropharmacology. 2017; 128:255-268.
PMID: 29042318 PMC: 5726399. DOI: 10.1016/j.neuropharm.2017.10.014.
Chen W, McRoberts J, Marvizon J Neuroscience. 2014; 267:67-82.
PMID: 24583035 PMC: 3998911. DOI: 10.1016/j.neuroscience.2014.02.023.
The combination of mitragynine and morphine prevents the development of morphine tolerance in mice.
Fakurazi S, Rahman S, Taufik Hidayat M, Ithnin H, Mohd Moklas M, Arulselvan P Molecules. 2013; 18(1):666-81.
PMID: 23292329 PMC: 6270191. DOI: 10.3390/molecules18010666.